# Masaki Mori

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/masaki-mori/

## Facts

| Field | Value |
| --- | --- |
| Citations | 62,124 |
| Field | Gastric Cancer Management and Outcomes |
| h-index | 112 |
| i10-index | 1,025 |
| Last Known Institution | Tokai University |
| OpenAlex ID | https://openalex.org/A5067647817 |
| ORCID iD | https://orcid.org/0000-0001-7632-3875 |
| Works | 2,141 |

## Researcher papers

- [Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers](https://scholariq.org/papers/two-foxp3-cd4-t-cell-subpopulations-distinctly-control-the-prognosis-of/)
- [Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs](https://scholariq.org/papers/reprogramming-of-mouse-and-human-cells-to-pluripotency-using-mature-micrornas/)
- [Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases](https://scholariq.org/papers/large-scale-genome-wide-association-study-in-a-japanese-population-identifies/)
- [Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer](https://scholariq.org/papers/exosomal-microrna-in-serum-is-a-novel-biomarker-of-recurrence-in-human/)
- [Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer](https://scholariq.org/papers/molecular-residual-disease-and-efficacy-of-adjuvant-chemotherapy-in-patients/)
- [Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma](https://scholariq.org/papers/circulating-microrna-21-as-a-novel-biomarker-for-hepatocellular-carcinoma/)
- [Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population](https://scholariq.org/papers/genomic-landscape-of-esophageal-squamous-cell-carcinoma-in-a-japanese-population/)
- [Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers](https://scholariq.org/papers/amplification-of-pvt-1-is-involved-in-poor-prognosis-via-apoptosis-inhibition-in/)
- [Defined factors induce reprogramming of gastrointestinal cancer cells](https://scholariq.org/papers/defined-factors-induce-reprogramming-of-gastrointestinal-cancer-cells/)
- [MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma](https://scholariq.org/papers/microrna-155-controls-exosome-synthesis-and-promotes-gemcitabine-resistance-in/)
- [Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer](https://scholariq.org/papers/oncogene-c-myc-promotes-epitranscriptome-m6a-reader-ythdf1-expression-in/)
- [ctDNA-based molecular residual disease and survival in resectable colorectal cancer](https://scholariq.org/papers/ctdna-based-molecular-residual-disease-and-survival-in-resectable-colorectal/)

## Researcher topics

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

## Researcher university

- [Tokai University](https://scholariq.org/institutions/tokai-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.